News about Biotechnology

India Poised to Become a Global Biopharma Leader: Anupriya Patel

Union Minister Anupriya Patel said India is well-positioned to become a global biopharma leader, highlighting the Biopharma SHAKTI initiative’s goal of launching 100 biologics by 2047. She urged the industry to strengthen capabilities in biologics and biosimilars.

Biotechnology | 12/06/2026 | By News Bureau

Roche and Nurix Partner to Develop BTK Degrader Bexobrutideg

Roche and Nurix Therapeutics have partnered to develop and commercialise bexobrutideg, a potential best-in-class BTK degrader for B-cell malignancies, chronic spontaneous urticaria, and Multiple Sclerosis (MS), aiming to overcome resistance to current BTK inhibitors.

Biotechnology | 09/06/2026 | By News Bureau

Made Scientific and Pluristyx Partner to Advance iPSC Cell Therapies

Made Scientific and Pluristyx have launched a strategic partnership to streamline iPSC-derived cell therapy development and manufacturing. By integrating Pluristyx’s clinical-grade iPSC platform with Made Scientific’s CDMO services, the collaboration provides developers with a single-source pathway from cell line development to commercial supply.

Biotechnology | 08/06/2026 | By News Bureau

Next-generation Nanomedicine can Silence Key Cancer Drivers: Research

Scientists in Pune have developed a next-generation precision nanomedicine that uses gene-silencing technology to target key cancer drivers and effectively inhibit breast tumor growth, highlighting a promising new approach for targeted breast cancer treatment and precision oncology.

Biotechnology | 04/06/2026 | By News Bureau

Illumina Unveils Whole-Genome Sequencing Solution for Sensitive MRD Detection

Illumina has launched the first distributed Whole-Genome Sequencing (WGS) solution for highly sensitive Molecular Residual Disease (MRD) research, enabling faster and more flexible detection of the disease during and after treatment while expanding its next-generation oncology sequencing portfolio.

Biotechnology | 02/06/2026 | By News Bureau

Leica Biosystems Expands Collaboration with AstraZeneca and Daiichi Sankyo to Advance AI-Powered Lung Cancer Biomarker Research

Leica Biosystems, AstraZeneca and Daiichi Sankyo have expanded their strategic collaboration to develop an AI-enabled immunohistochemistry assay and computational pathology solution for evaluating the TROP2 Normalised Membrane Ratio biomarker in NSCLC, aiming to advance biomarker-driven cancer research and future precision medicine approaches.<br />

Biotechnology | 01/06/2026 | By News Bureau |  109

Parse Biosciences and bit.bio Partner to Build Large-Scale Cell Identity Map for AI-Driven Drug Discovery

Parse Biosciences and bit.bio have announced a strategic alliance to develop a comprehensive transcription factor-driven cell identity map, leveraging advanced single-cell sequencing and cell programming technologies to improve predictive drug discovery and scalable therapeutic research.

Biotechnology | 29/05/2026 | By News Bureau |  100

Biocytogen Launches AI-Powered RenSuper Platform to Accelerate Therapeutic Antibody Discovery

Biocytogen unveils RenSuper, a next-generation AI-driven antibody discovery and automation platform designed to streamline therapeutic biologics development and accelerate the delivery of innovative medicines worldwide.

Biotechnology | 28/05/2026 | By News Bureau

Genethon and Ampersand Biomedicines Partner to Develop Precision Gene Therapy Vectors

Genethon and Ampersand Biomedicines join forces to engineer advanced AAV gene therapy vectors designed for greater tissue specificity, potentially enabling safer and more effective treatments for patients with rare genetic disorders.

Biotechnology | 25/05/2026 | By News Bureau

Incyte and Genesis Molecular AI Expand Strategic Collaboration to Accelerate AI-Driven Drug Discovery

Incyte and Genesis Molecular AI have expanded their strategic collaboration to deploy advanced molecular AI technologies and proprietary research data, aiming to accelerate drug discovery and develop next-generation therapies through AI-powered molecular design.

Biotechnology | 22/05/2026 | By News Bureau |  229